retatrutide weight loss clinical trials VisualAbstract: reduces body by 17.5% in patients with obesity Eli Lilly's Retatrutide Phase 3

Any use of Wegovy in this age group would need to be done under heightened clinical supervision and isnt common in practice

Resources used to make this article: FDA Clarifies policies as GLP1 supply stabilizes (semaglutide injection shortage resolved 2/21/2025): FDA Declaratory order (tirzepatide shortage resolved 12/19/2024, PDF): FDA Declaratory order (semaglutide injection shortage resolved 2/21/2025, PDF): FDA Concerns with unapproved GLP1s:

have designed and synthesized highly constrained GLP-1 analogs containing two or three lactam bridges between Glu i and Lys i +4 that were placed simultaneously to stabilize the both helical structures in the N- and C-terminal regions

While hypothyroidism is characterized by an underactive thyroid gland and reduced thyroid hormone production, hyperthyroidism is marked by an overactive thyroid gland and excess thyroid hormone production